Vaccine | Proportion With Seroconversion or Seroresponse (%)†| P-value (Adjusted For Village) | Relative Risk (95% CI) | |
---|---|---|---|---|
 | CH+ | CH- |  |  |
Measles | 127/137(93)* | 180/187 (96) | 0.16* | 0.96 (0.91–1.02)* |
 | 109/116 (94) |  | 0.36 | 0.98 (0.92–1.03) |
Diphtheria | 108/147(73)* | 116/135 (86) | 0.26* | 0.86 (0.76–0.96)*‡ |
 | 38/ 46 (83) |  | 0.59 | 0.96 (0.83–1.12) |
Tetanus | 104/134(77)* | 126/138 (91) | 0.08* | 0.85 (0.77–0.94)*‡ |
 | 41/43 (95) |  | 0.39 | 1.04 (0.96–1.14) |
Pertussis | 63/148(43) * | 113/168 (67) | <0.01* | 0.63 (0.51–0.78)* |
 | 17/44 (39) |  | <0.01 | 0.57 (0.39–0.85) |